Effects of cyclic AMP-elevating hormones and autacoids on LPS-activated rat peritoneal, bronchoalveolar and hepatic (Kupffer) macrophages

Cell Biochemistry and Function

Volumn 24, Issue 3, 2006, Pages 245-256

  Kondomerkos, Dimitrios J ^a   Kalamidas, Stefanos A ^a   Kotoulas, Othon B ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Activated macrophages; Cyclic AMP; Endotoxin; Nitric oxide

Indexed keywords

ADRENALIN; AUTACOID; BETA GLUCURONIDASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOPAMINE; ENDOTOXIN; HORMONE; INSULIN; LIPOPOLYSACCHARIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SIZE; CELL STRUCTURE; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; KUPFFER CELL; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

ANIMALS; AUTACOIDS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; DOPAMINE; EPINEPHRINE; FEMALE; HORMONES; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33646765770     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1205     Document Type: Article

References (56)

1. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
2. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080-5085.
3. Cooper PH, Mayer P, Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide. J Immunol 1984; 133: 913-922.
4. Liu MK, Herrera-Velit P, Brownsey RW, Reiner NE. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 1994; 153: 2642-2652.
5. Monick MM. Carter AB, Gundmundsson G, Mallampali R, Powers LS, Hunninghake GW. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide- stimulated human alveolar macrophages. J Immunol 1999; 162: 3005-3012.
6. Procyk KJ, Kovarik P, von Gabain A, Baccarini M. Salmonella lyphimurium and lipopolysaccharide stimulate extracellularly regulated kinase activation in macrophages by a mechanism involving phosphatidylinositol 3-kinase and phospholipase D as novel intermediates. Infect Immun 1999; 67: 1011-1017.
7. Sahl B, Wagey R, Marotta A, Tao JS, Pelech S. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated RAW 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J Immunol 1998; 161: 6947-6954.
8. Wu CC. Thiemermann C. Biological control and inhibition of induction of nitric oxide synthase. Methods Enzymol 1996; 268: 408-420.
9. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13: 85-94.
10. Chen CC, Chiu KT, Sun YT, Chen WC. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1999; 274: 31559-31564.
11. Muroi M, Suzuki T. Role of protein kinase A in LPS-induced activation of NF-κB proteins of a mouse macrophage-like cell line, J774. Cell Signal 1993; 5: 289-298.
12. Fujihara M, Muroi M, Muroi Y, Ito N, Suzuki T. Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J Biol Chem 1993; 268: 14898-14905.
13. Remold-O'Donnell E, Remold HG. The enhancement of macrophage adenylate cyclase by products of activated lymphocytes. J Biol Chem 1974; 249: 3622-3627.
14. Saito K, Suter E. Lysosomal acid hydrolases in mice infected with BCG. J Exp Res 1965; 121: 727-738.
15. Degre M, Sonnenfeld G, Rollag H, Morland B. Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Eschericia coli by mouse peritoneal macrophages. J Interferon Res 1981; 1: 505-512.
16. Akporiaye ET, Rowatt JD, Aragon AA, Baca OG. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetti. Infect Immun 1983; 40: 1155-1162.
17. Pierangeli SS, Sonnenfeld G. Effects of interferon-gamma and tumor necrosis factor-alpha on macrophage enzyme levels. J Interferon Res 1989; 9: 1-9.
18. Morland B, Kaplan G. Macrophage activation in vivo and in vitro. Exp Cell Res 1977; 108: 279-288.
19. Williams MA, Mayhew TM. Quantitative microscopical studies of the mouse peritoneal macrophage following stimulation in vitro. Z Zellforsch 1973; 140: 187-203.
20. Petty HR, Martin SM. Combinative ligand-receptor interactions: effects of cyclic AMP, epinephrine, and met-enkephalin on RAW264 macrophage morphology, spreading, adherence, and microfilaments. J Cell Physiol 1989; 138: 247-256.
21. Petty HR. Regulation of RAW264 macrophage morphology and spreading: studies with protein kinase C activators, inhibitors and a cyclic AMP analogue. Biochim Biophys Acta 1989; 1012: 284-290.
22. Kondomerkos DJ, Kalamidas SA, Kotoulas OB. In vitro effects of hormones and autacoids on the hydrogen peroxide production and the morphology of endotoxin-activated rat peritoneal macrophages. Histol Histopathol 2003; 18: 55-65.
23. Kondomerkos DJ, Kalamidas SA, Kotoulas OB. In vitro effects of hormones and autacoids on the activity of acid phosphatase in the lysates of endotoxin-activated rat peritoneal and bronchoalveolar macrophages. Histol Histopathol 2003; 18: 1103-1113.
24. European Council directive 86/609. Official Journal of the European Communities 1986; L358: 1-29.
25. US National Institutes of Health. Guide for the Use and Care of Laboratory Animals. NIH publication No. 85-23, revised 1996.
26. Lentz PE, Di Luzio NR. Isolation of adult rat liver macrophages (Kupffer cells). Methods Enzymol 1974; 32: 647-653.
27. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
29. Reichner JS, Mulligan JA, Bodenheimer HC. Electron transport chain activity in normal and activated rat macrophages. J Surg Res 1995; 59: 636-643.
30. Fishman WH, Springer B, Burnetti R. Application of an improved glucuronidase assay method to the study of human blood β-glucuronidase. J Biol Chem 1948; 173: 449-456.
31. Kim YK, Jang YY, Kim DH, Ko HH, Han ES, Lee CS. Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release and cytokine synthesis by activated murine peritoneal macrophages. Biochem Pharmacol 2001; 61: 87-96.
32. Remold-O'Donnel E. Stimulation and desensitization of macrophage adenylate cyclase by prostaglandins and catecholamines. J Biol Chem 1974; 249: 3615-3621.
33. Ikegami K. Modulation of adenosine 3′,5′-monophosphate contents of rat peritoneal macrophages mediated by β2-adrenergic receptors. Biochem Pharmacol 1977; 26: 1813-1816.
34. Yamamoto H, Suzuki T. Prostaglandin E2-induced activation of adenosine 3'-5'cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1). J Immunol 1987; 139: 3416-3421.
35. Hunt NH, Lim LK, Eichner RD, Buffinton GD, Weidemann MJ. Activation of cyclic AMP-dependent protein kinase in macrophages. Biochem Biophys Res Commun 1984; 119: 1082-1088.
36. Chijiwa T, Mishima A, Hagiwara M, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)- ethyl]-5-isoquinoline-sulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265: 5267-5272.
37. Galea E, Feinstein DL. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 1999; 13: 2125-2137.
38. Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW. PKA-dependent activation of PKC. p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 2004; 16: 565-575.
39. Metzger Z, Hoffeld JT, Oppenheim JJ. Regulation by PGE2 of the production of oxygen intermediates by LPS-activated macrophages. J Immunol 1981; 127: 1109-1113.
40. Mullet D, Fertel RH, Kniss D, Cox GW. An increase in intracellular cyclic AMP modulates nitric oxide production in INFγ-treated macrophages. J Immunol 1997; 158: 897-904.
41. Hasko G, Szabo C, Merkel K, et al. Modulation of lipopolysaccharide- induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol Lett 1996; 49: 143-147.
42. Hasko G, Szabo C, Nemeth ZH, Deitch EA. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a β-adrenoreceptor-mediated mechanism. J Neuroimmunol 2002; 122: 34-39.
43. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998: 1: 661-671.
44. Li X, Stark GR. NFκB-dependent signaling pathways. Exp Hematol 2002; 30: 285-296.
45. Alleva DG, Burger CJ, Elgert KD. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production. J Immunol 1994; 153: 1674-1686.
46. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and INF regulatory factor-1 activation. J Immunol 1999: 162: 4685-4696.
47. Rhodes J. Modulation of macrophage Fc-receptor expression in vitro by insulin and cyclic nucleotides. Nature 1975; 257: 597-599.
48. Muschel RJ, Rosen N, Rosen OM, Bloom BR. Modulation of Fc-mediated phagocytosis by cyclic AMP and insulin in a macrophage-like cell line. J Immunol 1977; 119: 1813-1820.
49. Walkenbach RJ, Hazen R, Larner J. Reversible inhibition of cyclic AMP-dependent protein kinase by insulin. Mol Cell Biochem 1978; 19: 31-41.
50. Heyworth CM, Houslay MD. Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase. Biochem J 1983; 214: 547-552.
51. Davis SN, Granner DK. Molecular mechanisms of insulin action. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (9th edn), Hardman JG, Limbird LE (eds). McGraw-Hill: New York, 1996; 1491-1493.
52. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J 1991; 278: 609-619.
53. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986; 94: 57-63.
54. Pozzolini M, Scarfi S, Benatti U, Giovine M. Interference in MTT cell viability assay in activated macrophage cell line. Anal Biochem 2003; 313: 338-341.
55. Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996; 135: 1249-1260.
56. Costa Rosa LF, Safi DA, Cury Y, Curi R. The effect of insulin on macrophage metabolism and function. Cell Biochem Funct 1996; 14: 33-42.